(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-acetoxy-9-((3-((tert-butoxycarbonyl)amino)-2-((tert-butyldimethylsilyl)oxy)-3-phenylpropanoyl)oxy)-11-hydroxy-4a,8,13,13-tetramethyl-5-oxo-4,6-bis((triethylsilyl)oxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxet-12-yl benzoate

In House Impurity

Stock Status : <%stockStatus%>

<%deliveryStatus%>

Catalogue number:	PA 04 0971043
Chemical name:	(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-acetoxy-9-((3-((tert-butoxycarbonyl)amino)-2-((tert-butyldimethylsilyl)oxy)-3-phenylpropanoyl)oxy)-11-hydroxy-4a,8,13,13-tetramethyl-5-oxo-4,6-bis((triethylsilyl)oxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxet-12-yl benzoate
CAS Number:	195141-96-9
Category:	impurities,metabolites,pharmaceutical standards,intermediates,Fine Chemicals
Synonyms:	NA
Molecular form:	C₆₁H₉₅NO₁₄Si₃
Appearance:	White Solid
Mol. Weight:	1150.68
Storage:	2-8°C Refrigerator
Shipping Conditions:	Ambient
Applications:	Docetaxel 2'-tert-Butyldimethylsilyl 7,10-Tris(triethylsilyl) Ether is an intermediate used in the synthesis of 2-Debenzoyl-2-pentenoyldocetaxel, which is a related compound of Docetaxel (D494420), a chemotherapy drug that exhibits anti-mitotic properties and used for treating various metastatic cancers.